[topsearch__bar__shortcode]

April 14, 2022

AI stock

Airgain Inc. (AIRG) Shining Premarket on Multimillion-dollar Contract to Deploy AirgainConnect®

The wireless connectivity technology company, Airgain Inc. (AIRG) stock is soaring high in today’s premarket on April 14, 2022. This upsurge is a result of the company securing a multi-million-dollar contract with a major utility. Hence, at the time of writing, the stock is trading at a price of $7.99 apiece after adding 14.14%. In

Airgain Inc. (AIRG) Shining Premarket on Multimillion-dollar Contract to Deploy AirgainConnect® Read More »

PLX stock

Protalix Bio Therapeutics Inc. (PLX) Rebounds Following Insider Transaction

On Wednesday, an SEC filing was revealed regarding the insider transaction of Protalix Bio Therapeutics Inc. (PLX) stock. The company’s CEO acquired some shares of its stock on April 11, according to the filing. PLX stock while lost 1.47% in the regular session on April 13, rebounded in the after-hours thanks to the insider transaction.

Protalix Bio Therapeutics Inc. (PLX) Rebounds Following Insider Transaction Read More »

BFRI stock

FDA Approval of Biofrontera Inc. (BFRI)’s Upsurge Falls Under Corrections After Hours

Biofrontera Inc. (BFRI) shares soared high on April 13, as its Germany lab got approval from FDA for testing skin disease therapy Ameluz®. But the upsurge fell under corrections in the after-hours as the stock began to shed its gains. BRFI stock was valued at $4.76 a share in the after-hours session, following a decline

FDA Approval of Biofrontera Inc. (BFRI)’s Upsurge Falls Under Corrections After Hours Read More »

GMTX stock

Gemini Therapeutics Inc. (GMTX) Up on Shares Purchase by a Major Shareholder

In a transaction on April 13, 2022, major shareholder Braden Michael Leonard acquired further shares of Gemini Therapeutics Inc. (GMTX). Disclosed in an SEC filing (13G), the purchase caused a rally in GMTX on Wednesday. GMTX shares went up by 11.97% in regular trading to reach a value of $1.59 per share. The stock then

Gemini Therapeutics Inc. (GMTX) Up on Shares Purchase by a Major Shareholder Read More »

ADVM stock

Adverum Biotechnologies Inc. (ADVM) Continues to Rise After Hours. Here’s why?

After being in the red for over a week, the gene therapy company, Adverum Biotechnologies Inc. (ADVM) became bullish on Wednesday. Gaining only 1.72% in the regular session, the bullish momentum spiked up in the after-hours to secure gains of 5.08%. Thus, ADVM was trading at a price of $1.24 per share in late trading

Adverum Biotechnologies Inc. (ADVM) Continues to Rise After Hours. Here’s why? Read More »

ARTL stock

Artelo Biosceinces Inc. (ARTL) Under Corrections After Upsurge on Positive Results from Lead Program

The development stage biopharma, Artelo Biosceinces Inc. (ARTL) was trending on April 13, due to positive results from its lead program in cancer-related Cachexia. The announcement of the results caused the stock to soar by 20.38% during the regular session on Wednesday. But the upsurge was ultimately followed by a fall in the after hours.

Artelo Biosceinces Inc. (ARTL) Under Corrections After Upsurge on Positive Results from Lead Program Read More »